Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T22:42:09.502Z.
Calculation as of: 2026-10-06T22:42:09.502Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 44fde230bfdd574c3cd4cd53b0628620ec84ec898484da9a9f15813d4ff0e801
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$584.48M
EV/FCF Ratio
N/A
TTM Avg
53.49x
3Y Avg
23.98x
5Y Avg
29.09x
Market Cap
$578.40M
EV/FCF Ratio
N/A
TTM Avg
19.46x
3Y Avg
19.46x
5Y Avg
19.46x
Market Cap
$596.01M
EV/FCF Ratio
1067.22x
TTM Avg
684.49x
3Y Avg
684.49x
5Y Avg
386.65x
Market Cap
$597.55M
EV/FCF Ratio
4.93x
TTM Avg
12.45x
3Y Avg
11.11x
5Y Avg
9.59x
Market Cap
$557.32M
EV/FCF Ratio
N/A
TTM Avg
34.57x
3Y Avg
33.80x
5Y Avg
13.57x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $583.31M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | N/A | 53.49x | 23.98x | 29.09x |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.40M | N/A | 19.46x | 19.46x | 19.46x |
| CorMedix Inc. (CRMD)vs › | $571.13M | 1.84x | 8.01x | 10.23x | 10.23x |
| AngioDynamics, Inc. (ANGO)vs › | $596.01M | 1067.22x | 684.49x | 684.49x | 386.65x |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 4.93x | 12.45x | 11.11x | 9.59x |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | N/A | 34.57x | 33.80x | 13.57x |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | 370.81x | 370.81x | 370.81x |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $548.51M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
